31.3400.54% ( -0.170 )
Closed: Oct 26, 16:00:00 (EDT)Current ValuationThe current P/E ratio is -2.59, below the reasonable range, cheaper than 89.27% of the time in the past 1 years, and the industry ranks 18/23, the industry Median 14.73.
-2.59xP/E
$31.34Stock price
$-12.10Earnings per share
-2.59xP/E
Stock price$31.34Earnings per share$-12.10
Historical Valuation
P/E ratioTypical rangeMedian
- P/E ratio
- -2.07x
- Typical range
- -2.38x–12.32x
Peer P/E ratio Comparison
It displays how the company's P/E ratio compares to top companies within its industry.
Industry median 14.73x
05101520
Industry P/E ratio Comparison
This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
Industry median 14.73x
0x10x20x30x40x50x
| Name/Symbol | |||
|---|---|---|---|
SGRYUSSurgery Partners | -34.35x | 8.20% | $3.04B |
ACHCUSAcadia Healthcare | -2.59x | 107.17% | $2.92B |
BKDUSBrookdale Senior Living | -16.85x | 102.72% | $2.33B |
SNDAUSSonida Senior Living | -11.09x | 14.93% | $1.61B |
STLNUSStarling Oncology | -20.97x | 70.00% | $641.05M |
RNVAUSRennova Health, Inc. | -- | -- | $40.55K |
IVPRUSInspire Veterinary Partners, Inc. | -0.00x | -- | $22.44K |
Risk Warning
Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.
